FEAT DAILY NEWSLETTER
Sacramento, California http://www.feat.org
March 14, 2001 Search
www.feat.org/search/news.asp
Also: ADHD/Ritalin Lawsuit Against American
Psychiatric
Association (APA) Dismissed
Judge Dismisses ADHD Lawsuit Against Shrinks
APA Praises Dismissal of ADHD Lawsuit as Victory
[From an American Psychiatric Association (APA)
press release.]
http://64.14.118.139/topnews/Current_Releases/0313-144.html
San Diego - U.S. Newswire - In what has been described by
the APA as “a victory for sound medicine and free speech,” a federal judge in California
has dismissed a class-action lawsuit claiming that the APA conspired with
others to improperly broaden the diagnosis of Attention Deficit/Hyperactive
Disorder (ADHD).
In a March 8 ruling, Senior U.S. District Judge Rudi
Brewster said the plaintiffs had failed to state a legally viable claim against
the APA and other defendants, and had produced no evidence to support their
allegations. In addition, the judge
ruled that activities by defendants intended to advance the medical
understanding, diagnosis and treatment of ADHD were free speech protected under
California’s anti-SLAPP (Strategic Lawsuits Against Public Participation)
statute.
“The ruling confirms that this lawsuit, and others like
it, have no basis in law or fact,” said Dr. Steven M. Mirin, medical director
for the APA, based in Washington, D.C. “ADHD is a real disease that requires professional
diagnosis and treatment. This is a victory for parents seeking to act in the
best interests of their children.”
The California lawsuit and similar suits filed in federal
courts in Texas, Florida and New Jersey claimed that APA had conspired with a
patient support group, Children and Adults with Attention Deficit/Hyperactivity
Disorder (CHADD), and a pharmaceutical company, Novartis, to invent or exaggerate
ADHD as a disorder. APA was specifically accused of improperly broadening the
clinical diagnosis of ADHD in its authoritative Diagnostic and Statistical
Manual of Mental Disorders.
“There is no evidence to support these outrageous claims”,
said Mirin, adding that he was “pleased, but not surprised” by the ruling. “The
existence of ADHD is based on a mountain of widely accepted scientific evidence
accumulated over decades of research, as well as clinical experience from treating—and
helping—millions of children,” he said.
Specifically, the judge ruled that:
·
APA and the other defendants in the suit “have met
their burden of showing that the anti-SLAPP statute applies, because the speech
at issue is clearly speech protected under the United States and California Constitutions
in connection with a public issue.”
·
The plaintiffs “failed to show misrepresentation of any
material facts, by whom any misrepresentations were made, when any
misrepresentations were made, and where any misrepresentations were made as
required by the Federal Rules of Civil Procedure.”
·
The complaint “fails to state a cause of action because
of a number of defects, including the absence of any allegations of causation, actionable
conduct or damage.”
Judge Brewster said the plaintiffs could amend their
complaint, but warned that he would dismiss the case again unless the
plaintiffs “could file a legally proper complaint and come forward with
sufficient evidence to proceed.”
Background from APA:
ADHD is the most commonly diagnosed behavior disorder of
childhood. It affects an estimated 3 to 5 percent of school-age children, 75
percent of them boys. An accurate diagnosis requires a thorough evaluation of
the child’s developmental, social, academic, family and medical history. Medication should be used only as part of a
comprehensive treatment plan that also includes psychotherapy, behavioral
treatment, and community-based support of teachers and guidance counselors.
The American Psychiatric Association, based in Washington,
D.C., was founded in 1844 and is the nation’s oldest medical society. It has
more than 38,000 members around the world who specialize in the diagnosis and treatment
of mental and emotional illnesses and substance use disorders.
An integral part of APA’s
mission is the publication of the Diagnostic and Statistical Manual of Mental
Disorders. First published in 1952 and periodically revised, the manual
provides comprehensive descriptions and classifications of mental disorders.
Its diagnostic criteria have been extensively tested for validity and
reliability in field trials supported by the National Institute of Mental
Health. The manual also reflects the participation of numerous international
health organizations, including the World Health Organization, prominent
medical and scientific associations (including the AMA and the National Academy
of Sciences), and public and private universities.
to work on a volunteer basis for the M.I.N.D. Institute
and for Families for Early Autism Treatment (FEAT).
You can advance critical autism research by assisting the
M.I.N.D. Institute in getting a
multitude of projects funded. The funds
are available for lack of the needed paperwork and the people to create
it. If you are interested and
experienced at writing grants, contact Kevin Duggan at kbduggan@ucdavis.edu
or 916 734-9676.
FEAT requires funding and support for the popular services
provided to families and their children with autism and the professionals who
serve them. In addition to the services
FEAT now provides, there is a need to start up an email-based autism “Hotline”
to meet the immediate needs of new families coming into the rapidly expanding
autism population. These are very “fundable”
services but again, we need help with the paperwork. Contact schafer@feat.org.
Lenny Schafer, Editor Catherine Johnson PhD
Ron Sleith Kay Stammers
Editor@feat.org Unsubscribe: FEATNews-signoff-request@LIST.FEAT.ORG
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.